Last updated on December 2019

Study To Evaluate the Efficacy Safety and Tolerability of E2027 in Participants With Dementia With Lewy Bodies

Brief description of study

This study will be conducted to compare E2027 to placebo on the cognitive endpoint of Montreal Cognitive Assessment (MoCA) and the global clinical endpoint of Clinician's Interview Based Impression of Change Plus (CIBIC-Plus) Caregiver Input in participants with dementia with Lewy bodies after 12 weeks of treatment.

Clinical Study Identifier: NCT03467152

Find a site near you

Start Over

Eisai Trial Site #13

Suita-shi, Japan
  Connect »

Eisai Trial Site #24

Suita-shi, Japan
  Connect »

Eisai Trial Site #21

Osaka, Japan
  Connect »

Eisai Trial Site #1

Naniwa-ku, Japan
  Connect »